(AXSM) Axsome Therapeutics - Performance 31.6% in 12m
AXSM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
45.30%
#18 in Peer-Group
Rel. Strength
79.38%
#1581 in Stock-Universe
Total Return 12m
31.62%
#30 in Peer-Group
Total Return 5y
42.01%
#41 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 137.75 USD |
| 52 Week Low | 80.05 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 71.63 |
| Buy/Sell Signal +-5 | -0.93 |
| Support / Resistance | Levels |
|---|---|
| Support | 107.1, 103.9, 99.9, 90.4, 83.8, 79.8 |
| Resistance |
12m Total Return: AXSM (31.6%) vs XLV (-6.9%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.6% | 122% | 354% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
1.31% | 13.6% | 82% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-3.22% | -16% | 419% | 64.5 | 36.4 | 1.21 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.96% | 0.58% | 50.8% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.31% | 3.35% | 50.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-4.42% | -7.1% | 49.9% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-4.46% | -8.98% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
4.59% | 19.6% | 62.6% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: AXSM vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AXSM
| Total Return (including Dividends) | AXSM | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 4.69% | -0.22% | 4.77% |
| 3 Months | 5.26% | -1.95% | 16.02% |
| 12 Months | 31.62% | -6.94% | 12.44% |
| 5 Years | 42.01% | 44.47% | 112.73% |
| Trend Score (consistency of price movement) | AXSM | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 54% | 32.3% | 90.3% |
| 3 Months | -2.6% | -15.4% | 97.5% |
| 12 Months | 76% | -78.9% | 46.4% |
| 5 Years | 60.8% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th58.00 | 4.91% | -0.08% |
| 3 Month | %th35.00 | 7.36% | -9.27% |
| 12 Month | %th86.00 | 41.44% | 17.05% |
| 5 Years | %th77.50 | -1.70% | -33.24% |
FAQs
Does Axsome Therapeutics (AXSM) outperform the market?
Yes,
over the last 12 months AXSM made 31.62%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.94%.
Over the last 3 months AXSM made 5.26%, while XLV made -1.95%.
Performance Comparison AXSM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AXSM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.9% | -0.1% | 14.2% | 19% |
| US NASDAQ 100 | QQQ | 1% | -0.6% | 12.2% | 19% |
| German DAX 40 | DAX | 0.6% | 1.6% | 2.1% | 2% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.3% | -0.4% | 9.7% | 12% |
| Hongkong Hang Seng | HSI | 0% | 0.8% | -7.8% | -3% |
| India NIFTY 50 | INDA | 2.3% | 3.1% | 13.7% | 35% |
| Brasil Bovespa | EWZ | 5.1% | 5% | -0.9% | 31% |
AXSM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.3% | 1.1% | 10.9% | 8% |
| Consumer Discretionary | XLY | -0% | -0.1% | 21.9% | 15% |
| Consumer Staples | XLP | 3% | 4.2% | 15.1% | 24% |
| Energy | XLE | -2% | 2.7% | 21.7% | 31% |
| Financial | XLF | 2.4% | -0.1% | 11.9% | 8% |
| Health Care | XLV | 0.8% | 4.9% | 25.7% | 39% |
| Industrial | XLI | 0.5% | -0.9% | 8.3% | 10% |
| Materials | XLB | 0.2% | -0.6% | 13.6% | 28% |
| Real Estate | XLRE | 1.2% | 4.6% | 15.7% | 25% |
| Technology | XLK | 1% | -2.5% | 9.1% | 22% |
| Utilities | XLU | 0.8% | 2.7% | 10.2% | 10% |
| Aerospace & Defense | XAR | 0.3% | -2.6% | -5.8% | -15% |
| Biotech | XBI | -2.7% | 0.6% | 24.4% | 44% |
| Homebuilder | XHB | -2.2% | -6.7% | 20.8% | 35% |
| Retail | XRT | 1% | -2.1% | 19% | 25% |
AXSM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.3% | 8.34% | 28.1% | 35% |
| Natural Gas | UNG | 2.6% | 13.5% | 40.2% | 29% |
| Gold | GLD | 0.8% | 7% | -3.7% | -6% |
| Silver | SLV | -3.4% | -1.6% | -7.9% | 7% |
| Copper | CPER | -9.4% | -11.2% | -5.4% | 8% |
AXSM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.8% | 4.9% | 19.5% | 35% |
| iShares High Yield Corp. Bond | HYG | 1.5% | 3.4% | 17.2% | 23% |